UniProtKB/Swiss-Prot Q96N87: Variant p.Gly496Arg

Inactive sodium-dependent neutral amino acid transporter B(0)AT3
Gene: SLC6A18
Feedback?

Variant information Variant position:

496 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Arginine (R) at position 496 (G496R, p.Gly496Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Genetic variation in SLC6A18 is not a significant predictor for elevated systolic or diastolic blood pressure and is not associated with hypertension in the Japanese population (PubMed:16340170). Additional information on the polymorphism described.
Other resources:

Links to websites of interest for the variant.

Variant rs147278493 [ dbSNP | Ensembl ]

Sequence information Variant position:

496 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

628 The length of the canonical sequence.
Location on the sequence:

ASPNLLMLAFLEVVGVVYVY G MKRFCDDIAWMTGRRPSPYW The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ASPNLLMLAFLEVVGVVYVYGMKRFCDDIAWMTGRRPSPYW

Mouse                         ASLNLIIFAFMEVVGVIHIYGMKRFCDDIEWMTGRRPGLYW

Rat                           ASLNLIIFAFMEVVGVIHVYGIKRFCDDIEWMTGRRPSLYW

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 628	Inactive sodium-dependent neutral amino acid transporter B(0)AT3
Transmembrane	475 – 497	Helical; Name=10

Literature citations
Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters.
Broer S.; Bailey C.G.; Kowalczuk S.; Ng C.; Vanslambrouck J.M.; Rodgers H.; Auray-Blais C.; Cavanaugh J.A.; Broer A.; Rasko J.E.;
J. Clin. Invest. 118:3881-3892(2008)
Cited for: VARIANTS SER-79; LEU-478 AND ARG-496; POSSIBLE INVOLVEMENT IN HG AND IG;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.